C.Uyemura & Co.,Ltd. (4966.T) Bundle
Who's buying C.Uyemura & Co., Ltd. (4966.T) - and why - becomes clearer when you dig into the numbers: the firm reported a TTM revenue of ¥84.79 billion (up 1.18% YoY) and a net income of ¥14.21 billion (a 28.92% increase for the year ended March 31, 2025), while offering a steady dividend yield of 1.97% and a payout ratio near 25% that attracts income-focused individuals; institutional investors - owning about 31.77% of shares - are led by Japan Trustee Services Bank (holding 5.2%), with Sumitomo Mitsui Trust Bank at 4.5% and Nomura Asset Management at 3.8%, and a management stake of 3.71% aligning insiders with shareholders; the stock's trailing P/E of 16.92 (forward P/E 16.50), a beta of 0.937, a 25% domestic market share in surface treatment chemicals, 20% growth in international sales, and a market capitalization now at ¥240.62 billion (up 36.47% year-over-year) explain why value, growth, dividend-seeking and risk-averse institutional investors are circling the company - read on to see how these stakeholders could shape C.Uyemura's next moves
C.Uyemura & Co.,Ltd. (4966.T) - Who Invests in C.Uyemura & Co.,Ltd. (4966.T) and Why?
- Individual investors - attracted by consistent revenue growth and steady income: TTM revenue ¥84.79 billion (Dec 2025), +1.18% YoY; dividend yield ~1.97% and payout ratio ~25%.
- Institutional investors (mutual funds, pension funds) - value low volatility and predictable cash flows: beta 0.937 indicating below-market volatility and stable earnings.
- Long-term investors - focus on market leadership and structural stability: 25% market share in Japan's surface treatment chemicals segment.
- Value investors - drawn to reasonable valuations: trailing P/E 16.92, forward P/E 16.50.
- Growth investors - encouraged by geographic expansion: international sales +20% year-over-year, signaling successful diversification.
- Dividend-seeking investors - prefer steady returns with capital retention: dividend payout ratio ~25% balancing distributions and reinvestment.
| Metric | Value | Relevance |
|---|---|---|
| TTM Revenue (Dec 2025) | ¥84.79 billion | Top-line scale for investor confidence |
| Revenue YoY | +1.18% | Stable incremental growth |
| Dividend Yield | ~1.97% | Income appeal |
| Dividend Payout Ratio | ~25% | Balance of payout and reinvestment |
| Beta | 0.937 | Lower volatility vs. market |
| Market Share (Surface Treatment, Japan) | 25% | Dominant domestic position |
| Trailing P/E | 16.92 | Valuation for value investors |
| Forward P/E | 16.50 | Expected near-term earnings valuation |
| International Sales Growth | +20% YoY | Growth and diversification driver |
- Risk profile alignment: conservative portfolios favor C.Uyemura for predictable cash flow and below-market volatility.
- Return profile alignment: blend investors get moderate growth plus dividends; specialized investors target market-dominant segments.
- Strategic investors: those seeking exposure to specialty chemicals with defensive characteristics and selective international upside.
C.Uyemura & Co.,Ltd. (4966.T) Institutional Ownership and Major Shareholders of C.Uyemura & Co.,Ltd. (4966.T)
Institutional investors hold a meaningful portion of C.Uyemura & Co.,Ltd. (4966.T), signaling confidence from professional money managers and trustees. Key ownership metrics and the largest holders are summarized below.
- Institutional ownership (Dec 2025): 31.77% of outstanding shares
- Insider ownership: 3.71%
- Market capitalization (Dec 15, 2025): ¥240.62 billion (up 36.47% year-over-year)
- Net income (fiscal year ended Mar 31, 2025): ¥14.21 billion (up 28.92% year-over-year)
Major institutional shareholders and their reported stakes:
| Shareholder | Stake (%) | Notes |
|---|---|---|
| Japan Trustee Services Bank, Ltd. | 5.2 | Largest institutional holder |
| Sumitomo Mitsui Trust Bank, Ltd. | 4.5 | Significant trust-bank position |
| Nomura Asset Management Co., Ltd. | 3.8 | Active asset manager exposure |
| Other institutional investors (aggregate) | 18.27 | Remaining institutional holdings to total 31.77% |
| Insiders (executives, directors) | 3.71 | Management-aligned ownership |
| Public / Retail | 64.52 | Residual free float |
Why institutions appear attracted to C.Uyemura:
- Strong recent profitability: net income of ¥14.21 billion, +28.92% YoY (FY Mar 31, 2025)
- Market-cap appreciation: ¥240.62 billion as of Dec 15, 2025, +36.47% YoY
- Substantial stewardship by major trust banks and asset managers (largest single institutional stake 5.2%)
- Management skin in the game: insider stake 3.71% aligns interests
For deeper financial context and ratios that institutional buyers likely consider, see: Breaking Down C.Uyemura & Co.,Ltd. Financial Health: Key Insights for Investors
C.Uyemura & Co.,Ltd. (4966.T) Key Investors and Their Impact on C.Uyemura & Co.,Ltd. (4966.T)
The shareholder base of C.Uyemura & Co.,Ltd. (4966.T) is characterized by major institutional holders, active insider participation, and improving operating results - a mix that shapes governance, capital allocation and market perception.
- The Japan Trustee Services Bank, Ltd. - 5.2%: largest institutional shareholder with capacity to influence board-level governance and strategic priorities through trustee voting.
- Sumitomo Mitsui Trust Bank, Ltd. - 4.5%: likely to push for shareholder-friendly policies (dividend consistency, capital efficiency) and prudent financial strategies.
- Nomura Asset Management Co., Ltd. - 3.8%: brings asset-management expertise, supporting disciplined portfolio and investment planning.
- Insiders - 3.71%: management ownership aligns executive incentives with external shareholders, improving likelihood of execution on long-term plans.
| Shareholder | Stake | Likely Impact |
|---|---|---|
| The Japan Trustee Services Bank, Ltd. | 5.2% | Governance influence; trustee-led voting on strategic decisions |
| Sumitomo Mitsui Trust Bank, Ltd. | 4.5% | Advocacy for shareholder returns and conservative financial policy |
| Nomura Asset Management Co., Ltd. | 3.8% | Asset-allocation and investment-planning expertise |
| Insider Ownership (management) | 3.71% | Alignment of management incentives with shareholders |
Key financial and market metrics that interact with investor behavior:
- FY ending Mar 31, 2025: net income increased by 28.92% - raises prospects for higher dividends or reinvestment into growth initiatives.
- Market capitalization: ¥240.62 billion (as of Dec 15, 2025) - enhances visibility and makes the stock more attractive to institutional and index investors.
| Metric | Value | Implication for Investors |
|---|---|---|
| Net income change (FY ended Mar 31, 2025) | +28.92% | Improved profitability supports dividends, buybacks, or growth capex |
| Market capitalization (Dec 15, 2025) | ¥240.62 billion | Greater institutional interest and index inclusion potential |
| Insider ownership | 3.71% | Management commitment to company performance |
How these elements interact:
- Institutional blockholders (JTSS, Sumitomo Mitsui Trust, Nomura AM) provide governance stability and pressure for capital-efficient policies when financial metrics (like the 28.92% net income rise) support returns.
- Insider ownership reduces agency risk and can accelerate strategic moves if management sees sustainable profit improvement.
- Large market cap increases liquidity and reduces cost of capital, enabling management to consider larger M&A or capex programs with institutional backing.
For a concise overview of the company's guiding principles alongside these investor dynamics, see: Mission Statement, Vision, & Core Values (2026) of C.Uyemura & Co.,Ltd.
C.Uyemura & Co.,Ltd. (4966.T) - Market Impact and Investor Sentiment
C.Uyemura & Co.,Ltd. (4966.T) has seen marked shifts in market perception driven by a combination of earnings growth, international expansion, and steady shareholder returns. As of December 15, 2025 the company's market capitalization rose 36.47% year-over-year to ¥240.62 billion, signaling broadening investor confidence in the company's growth trajectory and strategic execution.- Trailing P/E: 16.92 - indicates current valuation relative to past earnings.
- Forward P/E: 16.50 - suggests modest anticipated earnings growth built into current price.
- Beta: 0.937 - lower volatility than the market, appealing to risk-averse investors.
- Dividend yield: ~1.97% - supports income-focused ownership.
- Net income growth (FY ended Mar 31, 2025): +28.92% - strong profitability improvement.
- International sales growth: +20% YoY - successful geographic expansion.
| Metric | Value | Period / Note |
|---|---|---|
| Market Capitalization | ¥240.62 billion | As of Dec 15, 2025 (+36.47% YoY) |
| Trailing P/E | 16.92 | Trailing twelve months |
| Forward P/E | 16.50 | Analyst consensus forward EPS |
| Net Income Growth | +28.92% | FY ended Mar 31, 2025 vs prior year |
| International Sales Growth | +20% | YoY |
| Dividend Yield | ~1.97% | Current yield |
| Beta | 0.937 | Three- or five-year beta (market comparator) |
- Growth-focused institutions: attracted by double-digit net income growth and expanding international revenues.
- Value and income investors: drawn by mid-teens P/E and consistent dividend yield.
- Risk-averse investors and defensive funds: favor the lower volatility profile (beta 0.937).
- Cross-border strategic buyers: respond to 20% international sales growth as validation of overseas product-market fit.

C.Uyemura & Co.,Ltd. (4966.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.